Related Parties | (4) Related Parties For the three months ended September 30, 2016 and 2015, the Company recorded aggregate advisory/consulting revenue of $51,934 and $50,225, respectively. Of the advisory/consulting revenue recorded in 2016 and 2015, $43,970 and $33,786, respectively, is related party revenue for services performed on behalf of Nexcore Group LP and Bohemian Asset Management, Inc. For the nine months ended September 30, 2016 and 2015, the Company recorded aggregate advisory/consulting revenue of $136,384 and $154,439, respectively. Of the advisory/consulting revenue recorded in 2016 and 2015, $119,970 and $114,000, respectively, is related party revenue for services performed on behalf of Nexcore Group LP and Bohemian Asset Management, Inc. The Company, Nexcore and Bohemian are under common principal ownership. As of September 30, 2016 and December 31, 2015, the Company had $18,000 and $6,000, respectively, of accounts receivable from related parties. On November 1, 2015, our 1,645,000 common shares in NexCore Healthcare Capital Corp and our Class B units of NexCore Real Estate LLC was exchanged for 1,645,000 of common units of NexCore Companies LLC. In December 2015, the Company received a distribution of $274,715 or $0.167 per unit from Nexcore Companies LLC. The tax impact of the distribution was $5,510. Notes Receivable On October 17, 2014, we entered into a Promissory Note Agreement with WestMountain Distressed Debt, Inc., a related party, in the amount of $25,000. The note carried an interest rate of 18% per annum until paid in full. Repayment of the loan was due on or before April 16, 2015. On April 18, 2015, we entered into a new Promissory Note Agreement for the total principal and interest due on the original note as of April 18, 2015. The new principal amount was $27,256. The new note carried an interest rate of 18% per annum until paid in full. Repayment of the loan was due on or before October 18, 2015 and repayment was due on or before April 18, 2016. On October 18, 2015 we entered into a new Promissory Note Agreement for the total principal and interest due on the extension as of October 18, 2015. The new principal amount was $29,729. On January 27, 2015, we entered into a Promissory Note Agreement with WestMountain Distressed Debt, Inc., a related party, in the amount of $25,000. The note carried an interest rate of 18% per annum until paid in full. Repayment of the loan was due on or before July 27, 2015. On July 27, 2015, we entered into a new Promissory Note Agreement for the total principal and interest due on the original note as of July 27, 2015. The new principal amount was $27,244. The new note carried an interest rate of 18% per annum until paid in full. Repayment of the loan was due on or before January 27, 2016. As of December 31, 2015, principal and interest due on this note was $29,353. On January 27, 2016, we entered into a new Promissory Note Agreement for the total principal and interest due on the extension as of January 27, 2016 and repayment was due on or before July 29, 2016. The new principal amount was $29,730. On May 4, 2015, we entered into an additional Promissory Note Agreement with WestMountain Distressed Debt, Inc., a related party, in the amount of $10,000. The note carried an interest rate of 18% per annum until paid in full. Repayment of the loan was due on or before November 4, 2015. On November 4, 2015 we entered into a new Promissory Note Agreement for the total principal and interest due on the original note as of November 4, 2015 and repayment was due on or before May 5, 2016. The new principal amount was $10,740. On December 31, 2015 management evaluated the collectability of the notes and determined it was necessary to write the balances off. A total of $71,386 was expensed to the income statement. The Company has determined that WestMountain Distressed Debt, Inc., (WMDS) is considered a "variable interest entity", however, WestMountain Company is not the primary beneficiary. WestMountain Company provided funding to WMDS to assist in paying their current operational expenses. The Company is not the only financial supporter to WMDS. The first note was dated October 17, 2014. Below is a summary of the notes with WMDS that have been written off as of December 31, 2015. Note Due Accrued Date Date Principal Interest TOTALS 10/19/2015 4/19/2016 $ 29,729 $ 1,085 $ 30,814 7/27/2015 1/28/2016 27,244 2,109 29,353 11/5/2015 5/5/2016 10,740 479 11,219 TOTAL DUE $ 67,713 $ 3,673 $ 71,386 Write off due to uncertain collectability $ (71,386 ) Note receivable, related parties $ - WestMountain Company is not a majority equity stakeholder in WMDS, nor does it have voting control, control of the board of directors, or substantive management rights. Given that the Company does not have the power to direct their activities that most significantly impact its economic performance, the Company determined that it is not the primary beneficiary of WMDS and therefore is not required to consolidate this entity. The Company will assess any additional transactions with WMDS to determine if the entity will need to be consolidated with the Company based on the VIE disclosure requirements. As of September 30, 2016 and December 31, 2015, the following investments in marketable and nonmarketable securities were held in related parties due to common principal ownership: September 30, 2016 December 31, 2015 Marketable Securities: Company Name Shares Units Cost Shares Units Cost Hangover Joe's Holding Corporation 868,463 - $ 1,216 868,463 - $ 1,824 WestMountain Gold, Inc. 918,000 - 91,800 918,000 - 71,604 Total Shares or Units 1,786,463 - $ 93,016 1,786,463 - $ 73,428 Market/Fair Market/Fair Company Name Shares Units Value Shares Units Value Nonmarketable Securities: Nexcore Companies LLC (Common Units) - 1,645,000 1,645 - 1,645,000 $ 1,645 WestMountain Distressed Debt, Inc. 80,000 - - 80,000 - - Totals Shares or Units 80,000 1,645,000 $ 1,645 80,000 1,645,000 $ 1,645 On May 7, 2015 Omni Bio Pharmaceutical filed a Form 8-K. This company has been unsuccessful in its fundraising and partnering/licensing efforts and does not anticipate being able to raise sufficient capital to continue operations. Consequently, the Board of Directors of Omni Bio Parmaceutical approved an orderly wind down, including negotiations with its senior secured creditor, Bohemian Investments, LLC. This loss in value was deemed to be other than temporary and this investment was fully impaired during the nine months ended September 30, 2015 resulting in a loss on impairment of available for sale marketable securities of $193,634. |